{
    "2021-04-06": [
        [
            {
                "time": "2021-04-01",
                "original_text": "医药生物行业：为什么说智飞生物二季度有望迎来亮眼表现？",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "二季度",
                        "亮眼表现"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-04-05",
                "original_text": "药明康德(02359)拟认缴120 Capital, L.P.的约1588.09万美元份额投资生物科技企业",
                "features": {
                    "keywords": [
                        "药明康德",
                        "投资",
                        "生物科技"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-04-10",
                "original_text": "医药行业2021年4月投资月报：把握一季报最佳反弹窗口期 加配低估值且高增长标的",
                "features": {
                    "keywords": [
                        "医药行业",
                        "一季报",
                        "反弹窗口期",
                        "低估值",
                        "高增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-04-15",
                "original_text": "医药行业周报：当前是反弹最佳窗口期 加配低估值高增长标的",
                "features": {
                    "keywords": [
                        "医药行业",
                        "反弹",
                        "低估值",
                        "高增长"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-04-20",
                "original_text": "第四批国采执行，最新通知发布；Science揭示微生物与癌症的关系！或成为癌症治疗新路径丨贝壳日报",
                "features": {
                    "keywords": [
                        "国采",
                        "Science",
                        "微生物",
                        "癌症治疗"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-04-25",
                "original_text": "医药行业每周医览药闻：从2020年财报看国内创新药行业发展",
                "features": {
                    "keywords": [
                        "医药行业",
                        "财报",
                        "创新药"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-04-30",
                "original_text": "A股收盘综述：指数窄幅整理，氢能源及燃料电池概念股爆发",
                "features": {
                    "keywords": [
                        "A股",
                        "氢能源",
                        "燃料电池"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "新能源"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-05-05",
                "original_text": "东吴证券 - 医药生物行业：为何近期医疗服务、医美大幅上涨？【行业研究】",
                "features": {
                    "keywords": [
                        "东吴证券",
                        "医疗服务",
                        "医美",
                        "上涨"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-05-10",
                "original_text": "医疗板块走弱，药明康德跌4.16%，医疗ETF（512170）跌逾2%",
                "features": {
                    "keywords": [
                        "医疗板块",
                        "药明康德",
                        "下跌"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-05-15",
                "original_text": "医药行业周报：核心资产景气回归 关注第二批耗材集采进程",
                "features": {
                    "keywords": [
                        "医药行业",
                        "核心资产",
                        "耗材集采"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-05-20",
                "original_text": "2021年医药行业4月策略报告：Q1业绩高增长是股价核心催化剂",
                "features": {
                    "keywords": [
                        "医药行业",
                        "Q1业绩",
                        "高增长",
                        "股价催化剂"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-05-25",
                "original_text": "CRO板块闪崩，龙头药明康德、康龙化成双双跌超4%",
                "features": {
                    "keywords": [
                        "CRO板块",
                        "闪崩",
                        "药明康德",
                        "康龙化成"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-05-30",
                "original_text": "中信证券：关注经济复苏下盈利持续修复周期，特别是传统板块的低估值龙头",
                "features": {
                    "keywords": [
                        "中信证券",
                        "经济复苏",
                        "盈利修复",
                        "低估值龙头"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-06-01",
                "original_text": "JAMA：应对新冠病毒关键突变，疫苗保护效果远高于自然感染！",
                "features": {
                    "keywords": [
                        "JAMA",
                        "新冠病毒",
                        "疫苗",
                        "保护效果"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}